Simon-Pierre Gravel
- Professeur agrégé
-
Faculté de pharmacie
Pavillon Jean Coutu office 3196
Laboratoire : 514 343-6111 #3240
Web : ResearchGate
Web : PubMed
Web : LinkedIn
Web : Compte Twitter
Web : Google Scholar
Web : Autre site web
Doctorat
2011
, Pharmacie , Université de Montréal (Canada)
Études post-doctorales
2016
, Oncologie, Pharmacologie , Goodman Cancer Research Centre, Université McGill (Canada)
Affiliations
Research recruitment
My research laboratory is currently in the process of recruiting Master's or PhD students wishing to start their studies on May 1, 2018. If you are interested in the metabolic bases of inflammation and have the skills to undertake one or more original research programs, please send me a letter of intent, a curriculum vitae and the most recent academic transcripts at sp.gravel@umontreal.ca. Candidates presenting the best scientific records and skills will be contacted and met individually during an interview. Candidates must demonstrate good command of the English language.
Education Programs
- Health Sciences
Courses
- SBP1130 Biochimie et biologie cellulaire
- SBP1150 Éléments de biologie moléculaire et de génomique
- SBP2028 Laboratoire de biologie moléculaire pour sciences biopharmaceutiques
Expertises
Responsabilities and outreach Expand all Collapse all
Student supervision Expand all Collapse all
Cycle : Master's
Grade : M. Sc.
Research projects Expand all Collapse all
Investigating mitochondrial biogenesis rheostat functions in skin aging: stress sensing and control of immunometabolic landscapes Projet de recherche au Canada / 2023 - 2029
Investigating mitochondrial biogenesis rheostat functions in skin aging: stress sensing and control of immunometabolic landscapes Projet de recherche au Canada / 2023 - 2029
Long-lasting recovery of lysosomal acid lipase deficiency using non-viral delivery of non-integrating episomal DNA constructs. Projet de recherche au Canada / 2023 - 2029
Cardioprotective effect of a cyclic azapeptide ligand of CD36 against ischemia-reperfusion damage and dysfunction in mice Projet de recherche au Canada / 2021 - 2028
Phospholipid nanoparticles for lysosomal acid lipase deficiency gene replacement therapy Projet de recherche au Canada / 2022 - 2026
Design of nanoparticles for the targeted delivery of non-integrating constructs Projet de recherche au Canada / 2023 - 2025
Metabolic pathways control IRF-1 expression and improve response to immunotherapy in melanoma Projet de recherche au Canada / 2023 - 2025
Deciphering the regulation and role of PGC-1 transcriptional coactivators inhuman skin conditions Projet de recherche au Canada / 2020 - 2025
The PGC-1 metabolic coactivators control immunosuppression and response to immunotherapy in melanoma Projet de recherche au Canada / 2021 - 2024
Deciphering the regulation and role of PGC-1 transcriptional coactivators inhuman skin conditions Projet de recherche au Canada / 2018 - 2023
Highly versatile benchtop Flow Cytometry Analyzer Projet de recherche au Canada / 2019 - 2022
Repositionnement du fumarate de diméthyle pour traiter la COVID-19: une molécule à double action au potentiel antiviral et anti-inflammatoire Projet de recherche au Canada / 2020 - 2021
Réseau québécois de recherche sur les médicaments (RQRM) - Repositionnement du fumarate de diméthyle pour traiter la COVID-19: une molécule à double action au potentiel antiviral et anti-inflammatoire Projet de recherche au Canada / 2020 - 2021
Deciphering the regulation and role of PGC-1 transcriptional coactivators inhuman skin conditions Projet de recherche au Canada / 2018 - 2021
Mise en place d'un laboratoire d'immunopharmacologie métabolique Projet de recherche au Canada / 2017 - 2020
Publications Expand all Collapse all
Publications des 5 dernières années seulement
Gravel SP*, Ben Khalifa Y, McGuirk S, St-Louis C, Laurin KM, Lavallée É, Benas D, Desbouis S, Amaral F, D'Amours D, Breton L, Jäger S, St-Pierre J*. PGC-1s shape epidermal physiology by modulating keratinocyte proliferation and terminal differentiation. iScience. 2023 Mar 2;26(4):106314. doi: 10.1016/j.isci.2023.106314. eCollection 2023 Apr 21. (*= co-corresponding authors)
Zadory M, Lopez E, Babity S, Gravel SP, Brambilla D. Current knowledge on the tissue distribution of mRNA nanocarriers for therapeutic protein expression. Biomater Sci. 2022 Oct 25;10(21):6077-6115. doi: 10.1039/d2bm00859a.
Laurin KM*, Coutu-Beaudry K*, Salazar A, Méribout N, Audet-Walsh E, Gravel SP. Low expression of PGC-1β and other mitochondrial biogenesis modulators in melanoma is associated with growth arrest and the induction of an immunosuppressive gene expression program dependent on MEK and IRF-1. Cancer Lett. 2022 Aug 10;541:215738. doi: 10.1016/j.canlet.2022.215738. (* = contribution égale)
Mellal K, Omri S, Mulumba M, Tahiri H, Fortin C, Dorion MF, Pham H, Garcia Ramos Y, Zhang J, Pundir S, Joyal JS, Bouchard JF, Sennlaub F, Febbraio M, Hardy P, Gravel SP, Marleau S, Lubell WD, Chemtob S, Ong H. Immunometabolic modulation of retinal inflammation by CD36 ligand, Scientific Reports, 2019, sept 9; 9(1): 12903. doi: 10.1038/s41598-019-49472-8.
Gravel SP. Deciphering the Dichotomous Effects of PGC-1α on Tumorigenesis and Metastasis. Front Oncol. 2018 Mar 23;8:75. doi: 10.3389/fonc.2018.00075. eCollection 2018. Review
Hulea L*, Gravel SP*, Morita M*, Cargnello M, Uchenunu O, Im YK, Lehuédé C, Ma EH, Leibovitch M, McLaughlan S, Blouin MJ, Parisotto M, Papavasiliou V, Lavoie C, Larsson O, Ohh M, Ferreira T, Greenwood C, Bridon G, Avizonis D, Ferbeyre G, Siegel P, Jones RG, Muller W, Ursini-Siegel J, St-Pierre J, Pollak MN, Topisirovic I. Translational and HIF-1α-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides, Cell Metabolism, 2018, Dec 4;28(6):817-832.e8. doi: 10.1016/j.cmet.2018.09.001.
Shamalnasab M, Gravel SP, St-Pierre J, Jäger S, Breton L, Aguilaniu H. A salicylic acid derivative extends the lifespan of Caenorhabditis elegans by activating autophagy and the mitochondrial unfolded protein response, Aging Cell, 2018, Dec;17(6):e12830. doi: 10.1111/acel.12830.
Thivierge C, Tseng HW, Mayya V, Lussier C, Gravel SP, Duchaine T. Alternative polyadenylation confers Pten mRNAs stability and resistance to microRNAs, Nucleic Acids Research, 2018, Nov 2;46(19):10340-10352. doi: 10.1093/nar/gky666.
Im YK*, Najyb O, Gravel SP, McGuirk S, Ahn R, Avizonis D, Chenard V, Sabourin V, Hudson J, Pawson T, Topisirovic I, Pollak MN, St-Pierre J, Ursini-Siegel G. Interplay between ShcA signaling and PGC-1α triggers targetable metabolic vulnerabilities in breast cancer, Cancer Research, 2018, Sep 1;78(17):4826-4838. doi: 10.1158/0008-5472.CAN-17-3696.
Poffenberger MC, Metcalfe-Roach A, Aguilar E, Chen J, Hsu BE, Wong AH, Johnson RM, Flynn B, Samborska B, Ma EH, Gravel SP, Tonelli L, Devorkin L, Kim P, Hall A, Izreig S, Loginicheva E, Beauchemin N, Siegel PM, Artyomov MN, Lum JJ, Zogopoulos G, Blagih J, Jones RG. LKB1 deficiency in T cells promotes the development of gastrointestinal polyposis, Science, 2018, Jul 27;361(6400):406-411. doi: 10.1126/science.aan3975.
Thibault Houles, Simon-Pierre Gravel, Genevieve Lavoie, Sejeong Shin, Mathilde Savall, Antoine Meant, Benoit Grondin, Louis Gaboury, Sang-Oh Yoon, Julie St-Pierre, and Philippe Roux. RSK Regulates PFK-2 Activity to Promote Metabolic Rewiring in Melanoma. Cancer Res. 2018 Feb 12. pii: canres.2215.2017. doi: 10.1158/0008-5472.CAN-17-2215.
Communications Expand all Collapse all
Skin Research Group of Canada
RRCANCER
CRCQ
SIgnalisation Québec
Additional Information
Browse this profile on: